Home | Sitemap | Submit Content | Contact Us   
imageHome : Latest News : Merck Serono Resubmits U.S. Application for Cladribine Tablets as a Potential MS Therapy - PharmiWeb

Merck Serono Resubmits U.S. Application for Cladribine Tablets as a Potential MS Therapy - PharmiWeb

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service65 times read : Adjust font size: Decrease font Enlarge font
image

GENEVA, June 8, 2010 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Cladribine Tablets as a therapy for reducing relapses in people with relapsing forms of ...

Read this article...



Post your comment comment Comments (0 posted)

copyright